Watch-and-Wait for Breast Cancer: What Black Women Need to Know

For women diagnosed with a precancerous breast condition called ductal carcinoma in situ (DCIS), the standard treatment has often been surgery. However, groundbreaking research presented at the European Breast Cancer Conference suggests that a “watch-and-wait” approach, also known as active surveillance, might be a safe and effective alternative for those with low-risk DCIS. This finding is particularly significant for Black women, who often face unique challenges and disparities in breast cancer care.

Understanding the ‘Watch-and-Wait’ Approach

A recent clinical trial involving over 1,400 women with low-risk DCIS found that those on active surveillance had similar rates of developing invasive cancer compared to those who underwent immediate surgery. Dr. Jelle Wesseling, a lead researcher, noted that active surveillance doesn’t mean withholding treatment but rather closely monitoring patients, with surgery remaining an option at any time. This approach is already a recognized option for other low-risk cancers, like prostate cancer.

DCIS involves abnormal cells within the milk ducts, considered precancerous because they have the potential to spread. While typically treated with surgery, radiation, or hormone therapy, research indicates that a significant majority of DCIS cases—about 4 out of 5—never become invasive or life-threatening. This raises the important question of whether some women are receiving more treatment than necessary.

Why This Matters for Black Women

The implications of this research are especially critical for Black women. Studies consistently show that Black women experience significant disparities throughout their breast cancer journey, including later diagnoses, delayed treatment, and higher mortality rates compared to white women. These gaps are influenced not only by tumor biology but also by systemic barriers like access to quality care and healthcare inequities.

While a “watch-and-wait” strategy could potentially reduce overtreatment, it hinges on robust and consistent follow-up care. This includes regular mammograms, prompt access to specialists, and clear communication with healthcare providers. Without this essential support system, active surveillance could inadvertently increase risks.

Questions to Ask Your Doctor

If you are diagnosed with DCIS and your doctor suggests monitoring instead of immediate surgery, it’s vital to be informed and advocate for yourself. Consider asking these important questions:

• Is my DCIS considered low-risk, and what is the basis for that assessment?
• How frequently will I need imaging or check-ins?
• What specific symptoms or changes should I report immediately?
• If my condition progresses, how quickly can treatment begin?
• Would a second opinion from a breast specialist be beneficial?
• Does my personal risk profile or family history influence the best course of action for me?

Black women are also more likely to be diagnosed at a younger age and with more aggressive forms of breast cancer, making personalized decision-making paramount. Ensuring you have all the information and a customized treatment plan is essential.

Moving Forward with Informed Choices

The latest research offers a hopeful glimpse into potentially avoiding unnecessary surgeries for some women with low-risk DCIS. However, the safety of this approach is directly tied to consistent monitoring and equitable access to follow-up care. For Black women, advocating for comprehensive information, timely appointments, and tailored treatment plans from their healthcare teams is crucial for navigating these decisions safely and effectively.